{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:31:00Z","timestamp":1786728660192,"version":"build-2736575974"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pituitary adenomas are benign brain tumors that comprise 10%\u201320% of all central nervous system neoplasms. In recent years, stereotactic radiosurgery (SRS) has emerged as a highly effective treatment option in the management of functioning and nonfunctioning adenomas. It is associated with tumor control rates frequently ranging from 80% to 90% in published reports. While permanent morbidity is uncommon, potential side effects include endocrine dysfunction, visual field deficits, and cranial nerve neuropathies. In patients where single fraction SRS would pose an unacceptable risk (e.g. large lesion size or close proximity to the optic apparatus), hypofractionated SRS delivered in 1\u20135 fractions is a potential treatment option; however, available data are limited. A comprehensive literature search of PubMed\/MEDLINE, CINAHL, Embase, and the Cochrane Library was conducted to identify articles reporting on the use of SRS in functioning and nonfunctioning pituitary adenomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0028-3886.373631","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:30:03Z","timestamp":1692851403000},"page":"S133-S139","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Stereotactic Radiosurgery for Functioning and Nonfunctioning Pituitary Adenomas"],"prefix":"10.4103","volume":"71","author":[{"given":"Eric J","family":"Lehrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman O","family":"Kowalchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M","family":"Trifiletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20240907","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: A systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"R2-19-20240907","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol"},{"key":"R3-19-20240907","first-page":"762","article-title":"Management of hormone-secreting pituitary adenomas","volume":"19","author":"Mehta","year":"2017","journal-title":"Neuro Oncol"},{"key":"R4-19-20240907","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N Engl J Med"},{"key":"R5-19-20240907","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: A review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"R6-19-20240907","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11102-008-0163-x","article-title":"Adjuvant Gamma Knife radiosurgery in non-functioning pituitary adenomas; low risk of long-term complications in selected patients","volume":"12","author":"Hoybye","year":"2009","journal-title":"Pituitary"},{"key":"R7-19-20240907","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0889-8529(18)30209-3","article-title":"Radiation therapy of acromegaly","volume":"21","author":"Eastman","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R8-19-20240907","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1445-5994.1989.tb00246.x","article-title":"Long-term effects of megavoltage radiotherapy in acromegaly","volume":"19","author":"Lam","year":"1989","journal-title":"Aust N Z J Med"},{"key":"R9-19-20240907","first-page":"316","article-title":"The stereotaxic method and radiosurgery of the brain","volume":"102","author":"Leksell","year":"1951","journal-title":"Acta Chir Scand"},{"key":"R10-19-20240907","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/neuonc\/noz225","article-title":"Stereotactic radiosurgery for non-functioning pituitary adenomas: Meta-analysis and International Stereotactic Radiosurgery Society practice opinion","volume":"22","author":"Kotecha","year":"2020","journal-title":"Neuro Oncol"},{"key":"R11-19-20240907","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11060-017-2520-y","article-title":"Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: A multicenter study","volume":"135","author":"Cohen-Inbar","year":"2017","journal-title":"J Neurooncol"},{"key":"R12-19-20240907","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s12020-016-1081-8","article-title":"Frequency, pattern, and outcome of recurrences after gamma knife radiosurgery for pituitary adenomas","volume":"56","author":"Losa","year":"2017","journal-title":"Endocrine"},{"key":"R13-19-20240907","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1227\/NEU.0b013e318222afed","article-title":"Long-term outcomes after gamma knife stereotactic radiosurgery for nonfunctional pituitary adenomas","volume":"69","author":"Park","year":"2011","journal-title":"Neurosurgery"},{"key":"R14-19-20240907","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3171\/2013.3.JNS12766","article-title":"Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: A multicenter study","volume":"119","author":"Sheehan","year":"2013","journal-title":"J Neurosurg"},{"key":"R15-19-20240907","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/B:NEON.0000041887.51906.b7","article-title":"Stereotactic radiosurgery for pituitary adenomas: A review of the literature","volume":"69","author":"Laws","year":"2004","journal-title":"J Neurooncol"},{"key":"R16-19-20240907","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijrobp.2018.05.042","article-title":"Stereotactic shifts during frame-based image-guided stereotactic radiosurgery: Clinical measurements","volume":"102","author":"Dutta","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-19-20240907","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3171\/2015.4.JNS1573","article-title":"Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US","volume":"124","author":"Park","year":"2016","journal-title":"J Neurosurg"},{"key":"R18-19-20240907","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ijrobp.2021.10.008","article-title":"Reirradiation with stereotactic radiosurgery after local or marginal recurrence of brain metastases from previous radiosurgery","volume":"112","author":"Kowalchuk","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-19-20240907","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ijrobp.2021.01.048","article-title":"Treatment of WHO Grade 2 meningiomas with stereotactic radiosurgery: Identification of an optimal group for SRS using RPA","volume":"110","author":"Kowalchuk","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-19-20240907","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2020.01.030","article-title":"Single fraction radiosurgery, fractionated radiosurgery, and conventional radiotherapy for spinal oligometastasis (SAFFRON): A systematic review and meta-analysis","volume":"146","author":"Singh","year":"2020","journal-title":"Radiother Oncol"},{"key":"R21-19-20240907","first-page":"vdaa041","article-title":"Epidemiology of synchronous brain metastases","volume":"2","author":"Singh","year":"2020","journal-title":"Neurooncol Adv"},{"key":"R22-19-20240907","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2019.11.010","article-title":"Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches","volume":"144","author":"Singh","year":"2020","journal-title":"Radiother Oncol"},{"key":"R23-19-20240907","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.34087","article-title":"Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study","volume":"128","author":"Lehrer","year":"2022","journal-title":"Cancer"},{"key":"R24-19-20240907","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.3390\/ijms19103054","article-title":"Stereotactic radiosurgery and immune checkpoint inhibitors in the management of brain metastases","volume":"19","author":"Lehrer","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R25-19-20240907","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11060-020-03427-6","article-title":"Integration of immuno-oncology with stereotactic radiosurgery in the management of brain metastases","volume":"151","author":"Lehrer","year":"2021","journal-title":"J Neurooncol"},{"key":"R26-19-20240907","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2018.08.025","article-title":"Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data","volume":"130","author":"Lehrer","year":"2019","journal-title":"Radiother Oncol"},{"key":"R27-19-20240907","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","article-title":"Single versus multifraction stereotactic radiosurgery for large brain metastases: An international meta-analysis of 24 trials","volume":"103","author":"Lehrer","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R28-19-20240907","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/biomedicines9010031","article-title":"Proton and heavy particle intracranial radiosurgery","volume":"9","author":"Lehrer","year":"2021","journal-title":"Biomedicines"},{"key":"R29-19-20240907","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2020.05.010","article-title":"Clinical and radiographic adverse events after Gamma Knife radiosurgery for brainstem lesions: A dosimetric analysis","volume":"147","author":"Lehrer","year":"2020","journal-title":"Radiother Oncol"},{"key":"R30-19-20240907","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/cancers13010070","article-title":"The judicious use of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy in the management of large brain metastases","volume":"13","author":"Gutschenritter","year":"2020","journal-title":"Cancers (Basel"},{"key":"R31-19-20240907","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijrobp.2016.06.009","article-title":"Stereotactic radiosurgery for brainstem metastases: An international cooperative study to define response and toxicity","volume":"96","author":"Trifiletti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R32-19-20240907","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-6-48","article-title":"Stereotactic radiosurgery for brain metastases: Analysis of outcome and risk of brain radionecrosis","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"key":"R33-19-20240907","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ijrobp.2013.03.037","article-title":"Multidose stereotactic radiosurgery (9 Gy\u00d73) of the postoperative resection cavity for treatment of large brain metastases","volume":"86","author":"Minniti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-19-20240907","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ijrobp.2016.03.013","article-title":"Single-fraction versus multifraction (3\u00d79 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: A comparative analysis of local control and risk of radiation-induced brain necrosis","volume":"95","author":"Minniti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R35-19-20240907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.2007.106.1.1","article-title":"Stereotactic radiosurgery--an organized neurosurgery-sanctioned definition","volume":"106","author":"Barnett","year":"2007","journal-title":"J Neurosurg"},{"key":"R36-19-20240907","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R37-19-20240907","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992-2007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-19-20240907","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3171\/2013.7.JNS13217","article-title":"Results of gamma knife surgery for Cushing's disease","volume":"119","author":"Sheehan","year":"2013","journal-title":"J Neurosurg"},{"key":"R39-19-20240907","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3171\/jns.2000.93.supplement_3.0006","article-title":"Radiosurgery for growth hormone-producing pituitary adenomas","volume":"93","author":"Zhang","year":"2000","journal-title":"J Neurosurg"},{"key":"R40-19-20240907","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3171\/jns.2007.106.5.833","article-title":"Radiosurgery of growth hormone-producing pituitary adenomas: Factors associated with biochemical remission","volume":"106","author":"Pollock","year":"2007","journal-title":"J Neurosurg"},{"key":"R41-19-20240907","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3171\/jns.2000.93.supplement_3.0010","article-title":"Gamma knife radiosurgery as a primary treatment for prolactinomas","volume":"93","author":"Pan","year":"2000","journal-title":"J Neurosurg"},{"key":"R42-19-20240907","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing's disease: Initial outcome and long-term results","volume":"89","author":"Hammer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-19-20240907","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.2007-2013","article-title":"Late recurrences of Cushing's disease after initial successful transsphenoidal surgery","volume":"93","author":"Patil","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-19-20240907","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1227\/01.NEU.0000313117.35824.9F","article-title":"Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease","volume":"63","author":"Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws","year":"2008","journal-title":"Neurosurgery"},{"key":"R45-19-20240907","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3171\/JNS\/2008\/109\/10\/0751","article-title":"Management of Cushing's disease: Outcome in patients with microadenoma detected on pituitary magnetic resonance imaging","volume":"109","author":"Prevedello","year":"2008","journal-title":"J Neurosurg"},{"key":"R46-19-20240907","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/eje.1.02323","article-title":"Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease","volume":"156","author":"Castinetti","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R47-19-20240907","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11102-014-0584-7","article-title":"Gamma knife radiosurgery for Cushing's disease and Nelson's syndrome","volume":"18","author":"Marek","year":"2015","journal-title":"Pituitary"},{"key":"R48-19-20240907","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jocn.2013.04.007","article-title":"Cushing's disease: A single centre's experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy","volume":"21","author":"Wilson","year":"2014","journal-title":"J Clin Neurosci"},{"key":"R49-19-20240907","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3171\/2016.9.JNS161163","article-title":"Characterizing and predicting the Nelson-Salassa syndrome","volume":"127","author":"Graffeo","year":"2017","journal-title":"J Neurosurg"},{"key":"R50-19-20240907","doi-asserted-by":"crossref","first-page":"731","DOI":"10.7326\/0003-4819-85-6-731","article-title":"Nelson's syndrome: Frequency, prognosis, and effect of prior pituitary irradiation","volume":"85","author":"Moore","year":"1976","journal-title":"Ann Intern Med"},{"key":"R51-19-20240907","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2265.1998.00578.x","article-title":"A study of patients with Nelson's syndrome","volume":"49","author":"Pereira","year":"1998","journal-title":"Clin Endocrinol (Oxf"},{"key":"R52-19-20240907","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s002689910020","article-title":"Long-term results of total adrenalectomy for Cushing's disease","volume":"24","author":"Nagesser","year":"2000","journal-title":"World J Surg"},{"key":"R53-19-20240907","first-page":"165","article-title":"The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome","volume":"80","author":"Jenkins","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-19-20240907","first-page":"124","article-title":"Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene","volume":"81","author":"Karl","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R55-19-20240907","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.surg.2006.12.003","article-title":"Nelson's syndrome after bilateral adrenalectomy for Cushing's disease","volume":"141","author":"Gil-Cardenas","year":"2017","journal-title":"Surgery"},{"key":"R56-19-20240907","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3171\/jns.2001.95.2.0285","article-title":"Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma","volume":"95","author":"Ikeda","year":"2001","journal-title":"J Neurosurg"},{"key":"R57-19-20240907","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/neuros\/nyy178","article-title":"Stereotactic radiosurgery for acromegaly: An international multicenter retrospective cohort study","volume":"84","author":"Ding","year":"2019","journal-title":"Neurosurgery"},{"key":"R58-19-20240907","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A Consensus Statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"R59-19-20240907","doi-asserted-by":"crossref","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","article-title":"The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new","volume":"33","author":"Chanson","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R60-19-20240907","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-012-0376-x","article-title":"Gamma knife stereotactic radiosurgery for drug resistant or intolerant invasive prolactinomas","volume":"16","author":"Liu","year":"2013","journal-title":"Pituitary"},{"key":"R61-19-20240907","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2002-36708","article-title":"Gonadotropinomas","volume":"20","author":"Chaidarun","year":"2002","journal-title":"Semin Reprod Med"},{"key":"R62-19-20240907","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1210\/jc.2004-0875","article-title":"Clinically silent somatotropinomas may be biochemically active","volume":"90","author":"Sakharova","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-19-20240907","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/EJE-11-0216","article-title":"Clinically silent somatotroph adenomas are common","volume":"165","author":"Wade","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R64-19-20240907","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1227\/NEU.0b013e318257c1f0","article-title":"Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas","volume":"71","author":"Ioachimescu","year":"2012","journal-title":"Neurosurgery"},{"key":"R65-19-20240907","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ijrobp.2014.07.013","article-title":"Silent corticotroph adenomas after stereotactic radiosurgery: A case-control study","volume":"90","author":"Xu","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R66-19-20240907","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2265.2003.01674.x","article-title":"Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently","volume":"58","author":"Bradley","year":"2003","journal-title":"Clin Endocrinol (Oxf"},{"key":"R67-19-20240907","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1365-2265.2009.03673.x","article-title":"Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas","volume":"72","author":"Cho","year":"2010","journal-title":"Clin Endocrinol (Oxf"},{"key":"R68-19-20240907","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12672-010-0014-x","article-title":"Silent corticogonadotroph adenomas: Clinical and cellular characteristics and long-term outcomes","volume":"1","author":"Cooper","year":"2010","journal-title":"Horm Cancer"},{"key":"R69-19-20240907","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1227\/01.neu.0000429858.96652.1e","article-title":"A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas","volume":"73","author":"Jahangiri","year":"2013","journal-title":"Neurosurgery"},{"key":"R70-19-20240907","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-10-0076","article-title":"Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease","volume":"163","author":"Raverot","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"R71-19-20240907","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000478-200304000-00007","article-title":"Silent corticotroph carcinoma of the adenohypophysis: A report of five cases","volume":"27","author":"Roncaroli","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R72-19-20240907","first-page":"723","article-title":"Clinically silent corticotroph tumors of the pituitary gland","volume":"47","author":"Scheithauer","year":"2000","journal-title":"Neurosurgery"},{"key":"R73-19-20240907","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1227\/01.NEU.0000088660.16904.F7","article-title":"Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study","volume":"53","author":"Webb KM, Laurent JJ, Okonkwo DO, Lopes MB, Vance ML, Laws","year":"2003","journal-title":"Neurosurgery"},{"key":"R74-19-20240907","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11102-014-0624-3","article-title":"Silent corticotroph adenomas","volume":"18","author":"Cooper","year":"2015","journal-title":"Pituitary"},{"key":"R75-19-20240907","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00701-012-1378-1","article-title":"Clinical features of silent corticotroph adenomas","volume":"154","author":"Alahmadi","year":"2012","journal-title":"Acta Neurochir (Wien"},{"key":"R76-19-20240907","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11060-010-0302-x","article-title":"A prospective study of nonfunctioning pituitary adenomas: Presentation, management, and clinical outcome","volume":"102","author":"Chen","year":"2011","journal-title":"J Neurooncol"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.373631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:30:04Z","timestamp":1786725004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.373631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":76,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/0028-3886.373631","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}